BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 14632312)

  • 21. Mutational analysis of the STAT6 SH2 domain.
    Mikita T; Daniel C; Wu P; Schindler U
    J Biol Chem; 1998 Jul; 273(28):17634-42. PubMed ID: 9651359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of a new conformation-constrained L-tyrosine analogue as a potential scaffold for SH2 domain ligands.
    Liu F; Zha HY; Yao ZJ
    J Org Chem; 2003 Aug; 68(17):6679-84. PubMed ID: 12919032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of lipopolysaccharide-response genes in B-lineage cells demonstrates that they can have differentiation stage-restricted expression and contain SH2 domains.
    Kerr WG; Heller M; Herzenberg LA
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):3947-52. PubMed ID: 8632995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a novel truncated isoform of trkB in the kitten primary visual cortex.
    Forooghian F; Kojic L; Gu Q; Prasad SS
    J Mol Neurosci; 2001 Aug; 17(1):81-8. PubMed ID: 11665865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptide-mediated targeting of liposomes to TrkB receptor-expressing cells.
    Ranjan S; Sood R; Dudas J; Glueckert R; Schrott-Fischer A; Roy S; Pyykkö I; Kinnunen PK
    Int J Nanomedicine; 2012; 7():3475-85. PubMed ID: 22848172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Microdetermination of tyrosine by the aid of the color reaction with alpha-nitroso-beta-naphthol].
    MASSIN M; LINDENBERG AB
    Bull Soc Chim Biol (Paris); 1957 Sep; 39(9-10):1201-3. PubMed ID: 13472337
    [No Abstract]   [Full Text] [Related]  

  • 27. SH2B1 regulation of energy balance, body weight, and glucose metabolism.
    Rui L
    World J Diabetes; 2014 Aug; 5(4):511-26. PubMed ID: 25126397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuronal SH2B1 is essential for controlling energy and glucose homeostasis.
    Ren D; Zhou Y; Morris D; Li M; Li Z; Rui L
    J Clin Invest; 2007 Feb; 117(2):397-406. PubMed ID: 17235396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SH2 domains: role, structure and implications for molecular medicine.
    Waksman G; Kumaran S; Lubman O
    Expert Rev Mol Med; 2004 Jan; 6(3):1-18. PubMed ID: 14987415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of SH2-B to phosphorylated tyrosine residues in the activation loop of TrkB.
    Suzuki K; Mizutani M; Hitomi Y; Kizaki T; Ohno H; Ishida H; Haga S; Koizumi S
    Res Commun Mol Pathol Pharmacol; 2002; 111(1-4):27-39. PubMed ID: 14632312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor.
    Easton JB; Royer AR; Middlemas DS
    J Neurochem; 2006 May; 97(3):834-45. PubMed ID: 16573649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor.
    Godeny MD; Sayyah J; VonDerLinden D; Johns M; Ostrov DA; Caldwell-Busby J; Sayeski PP
    Cell Signal; 2007 Mar; 19(3):600-9. PubMed ID: 17027227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PSM/SH2-B distributes selected mitogenic receptor signals to distinct components in the PI3-kinase and MAP kinase signaling pathways.
    Deng Y; Xu H; Riedel H
    J Cell Biochem; 2007 Feb; 100(3):557-73. PubMed ID: 16960871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IREM-1 is a novel inhibitory receptor expressed by myeloid cells.
    Alvarez-Errico D; Aguilar H; Kitzig F; Brckalo T; Sayós J; López-Botet M
    Eur J Immunol; 2004 Dec; 34(12):3690-701. PubMed ID: 15549731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation loop phosphorylation-independent kinase activity of human protein kinase C zeta.
    Ranganathan S; Wang Y; Kern FG; Qu Z; Li R
    Proteins; 2007 May; 67(3):709-19. PubMed ID: 17335005
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.